Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-13 · accession 0001209191-23-003563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-17 | 2023-01-13 | HRTX | Quart Barry D | CEO, Dir | M - OptEx | — | +19.8K | 183.2K | +12% | — |
| D | 2023-01-17 | 2022-10-31 | HRTX | Quart Barry D | CEO, Dir | J - Other | $3.27 | +1,655 | 163.4K | +1% | +$5,412 |
| D | 2023-01-17 | 2023-01-13 | HRTX | Quart Barry D | CEO, Dir | F - Tax | $3.17 | -5,219 | 178.0K | -3% | -$16.5K |
| DM | 2023-01-17 | 2023-01-13 | HRTX | Quart Barry D | CEO, Dir | M - OptEx | $0.00 | -19.8K | 25.5K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-13 | M | A | 3,645 | — | 167,086 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2022-10-31 | J | A | 1,655 | $3.27 | 163,441 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-13 | M | A | 16,122 | — | 183,208 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2023-01-13 | F | D | 5,219 | $3.17 | 177,989 | D | — | — | (F3) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. |
| 5 | Derivative | Restricted Stock Units | 2023-01-13 | M | D | 16,122 | $0.00 | 114,807 | D | — · — to — | 16,122 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F5) The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). |
| 6 | Derivative | Restricted Stock Units | 2023-01-13 | M | D | 3,645 | $0.00 | 25,521 | D | — · — to — | 3,645 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). |